Suresh Muthukumaraswamy

@sdmuthu.bsky.social

Researcher at University of Auckland. Ivory tower inhabitant. Views are mine. https://scholar.google.co.uk/citations?user=VU4GTNsAAAAJ&hl=en&oi=ao

Yet another pointless (scientifically speaking) study of psychedelics. With no placebo response the design is clearly a mess. I guess you can juice your stock price but you’ll never see this get published … and if you don’t publish your participant information sheets then don’t bother ….

josh hardman@josh-hardman.bsky.social · 2y ago

Shares in GH Research ( $GHRS ) surged today as the company announced positive results from a Phase 2b study of its inhaled 5-MeO-DMT candidate for treatment-resistant depression. Here's a summary (image). And more: psychedelicalpha.com/news/gh-rese...

This won’t be a popular view on the left but as a clinical trialist I am not sad to see the TPA go. The current clinical trial system works pretty well actually but the TPA had lots of uncertainty/undefined things in it - definitions that could have been really bad….

Sarah Pallett@sarah4ilam.bsky.social · 2y ago

I’m particularly salty about the repeal of the Therapeutic Products Act going through all stages under urgency today. My relative who sells magic oxygenated water that cures cancer* and protects against COVID* because vaccines are evil^ is delighted, however. * it doesn’t x2 ^ they are not #nzpol

Complexity in MEG/EEG. My prediction is that a good number of results are not actually showing changes in brain “complexity” but reflect spectral power changes - failing to use surrogate data properly. Some bright PhD/PostDoc should do this. Will make a great paper. I’m too time poor else I would…

Psychopharmacology gets lots of criticism from psychotherapy/adjacent folks. But if someone could send me therapy trials that 1. Are double-triple blind 2. Carefully document/report AEs 3. Pre-register an SAP with ITT I would appreciate. I will wait ….

I feel my initial post on the Dodo bird may have been completely side-tracked into a debate on the MAPS model (which at the end of the day doesn’t much interest me)…. But at least some discussion because honestly blue sky has been kind of dull so far …

Suresh Muthukumaraswamy@sdmuthu.bsky.social · 2y ago

Been reading quite a bit of psychotherapy research lately. If one accepts the Dodo Bird Verdict (which is not an unreasonable position) then it really doesn’t matter what type of therapy is used in PAT (as long as not harmful) even if that therapy is based on odd principles …

Been reading quite a bit of psychotherapy research lately. If one accepts the Dodo Bird Verdict (which is not an unreasonable position) then it really doesn’t matter what type of therapy is used in PAT (as long as not harmful) even if that therapy is based on odd principles …